Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

Dexcom has rounded up its celebrity spokespeople for World Diabetes Day, putting singer Nick Jonas at the center of a ...

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

David Padilla, 77, a Westbury resident, has been living with type 2 diabetes for over 40 years and continues to live life to ...

DexCom, Inc. (NASDAQ:DXCM) is a medical device company, which focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the US and internationally.

StockNews.com lowered shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a research report report published on Saturday. A number of other analysts have also weighed in ...

On Friday, DexCom Inc (DXCM) stock saw a modest uptick, ending the day at $75.88 which represents a slight increase of $1.20 or 1.61% from the prior close of $74.68. The stock opened at $75.51 and ...

However, there remain good reasons to invest in the company. Let's first review what DexCom does. The company is a leader in ...

US-based medical device firm Dexcom Inc has officially opened its new manufacturing facility in Batu Kawan, Penang, marking ...